FDA 483 - Allergan Sales LLC - December 12, 2025

Allergan Sales LLC in Cincinnati, OH, was inspected by the FDA from December 8-12, 2025. The inspection revealed that the firm failed to maintain an adequate quantity of reserve drug product samples necessary for all required tests, including microbiological examination. This deficiency indicates a potential issue with quality control and adherence to internal standard operating procedures.